Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Williams, J. M.
* Articles by Foulds, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Williams, J. M.
* Articles by Foulds, J.
Related Collections
* Nicotine
* Schizophrenia Spectrum Disorders
Psychiatr Serv 55:1064-1066, September 2004
© 2004 American Psychiatric Association


Brief Report

A Case Series of Nicotine Nasal Spray in the Treatment of Tobacco Dependence Among Patients With Schizophrenia

Jill M. Williams, M.D., Douglas M. Ziedonis, M.D., M.P.H. and Jonathan Foulds, Ph.D.

A retrospective case series of 12 smokers with schizophrenia or schizoaffective disorder who had not successfully quit smoking with previous treatments for tobacco dependence were treated with nicotine nasal spray. All but one patient (92 percent) tolerated the nasal spray well, and nine (75 percent) used it at maximal doses for prolonged periods. After treatment five patients (42 percent) were abstinent from smoking for more than 90 days, and four patients (33 percent) substantially reduced the amount that they smoked. Ten patients (83 percent) used the spray in combination with other medications, and all received psychosocial support. Nicotine nasal spray was found to be well tolerated.




This article has been cited by other articles:


Home page
Schizophr BullHome page
J. J. Prochaska, S. M. Hall, and L. A. Bero
Tobacco Use Among Individuals With Schizophrenia: What Role Has the Tobacco Industry Played?
Schizophr Bull, May 1, 2008; 34(3): 555 - 567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. M. Williams and J. Foulds
Successful Tobacco Dependence Treatment in Schizophrenia
Am J Psychiatry, February 1, 2007; 164(2): 222 - 227.
[Full Text] [PDF]


Home page
Tobacco ControlHome page
D E Apollonio and R E Malone
Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill
Tob. Control, December 1, 2005; 14(6): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. FOULDS and J. WILLIAMS
Tobacco Use and Cataracts in Patients With Schizophrenia
Am J Psychiatry, May 1, 2005; 162(5): 1028 - 1028.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org